Location · Kansas City, KS
Clinical trials in Kansas City, KS
148 recruiting studies have a site in Kansas City, and 30 of them accept healthy volunteers.
148 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Cumberland Pharmaceuticals
- Location
- Kansas City, KS + 17 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 2
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
AstraZeneca
- Location
- Kansas City, KS + 7 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Pulmovant, Inc.
- Location
- Kansas City, KS + 12 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Inhibikase Therapeutics
- Location
- Kansas City, KS + 14 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Novartis Pharmaceuticals
- Location
- Kansas City, KS + 42 other US sites
- Eligibility basics
- Ages 40–70
- RecruitingPhase 2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Immunovant Sciences GmbH
- Location
- Kansas City, KS + 54 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
UniQure Biopharma B.V.
- Location
- Kansas City, KS + 15 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Boehringer Ingelheim
- Location
- Kansas City, KS + 9 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Amgen
- Location
- Kansas City, KS + 193 other US sites
- Eligibility basics
- Ages 50–105
- RecruitingPhase 2
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
- Location
- Kansas City, KS + 27 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
BlueRock Therapeutics
- Location
- Kansas City, KS + 33 other US sites
- Eligibility basics
- Ages 45–75
- RecruitingPhase 3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Janssen Research & Development, LLC
- Location
- Kansas City, KS + 10 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Maze Therapeutics
- Location
- Kansas City, KS + 58 other US sites
- Eligibility basics
- Ages 18–68
- RecruitingPhase 3
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
United Therapeutics
- Location
- Kansas City, KS + 73 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
4D-710 in Adult Patients With Cystic Fibrosis
4D Molecular Therapeutics
- Location
- Kansas City, KS + 17 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
GlaxoSmithKline
- Location
- Kansas City, KS + 7 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Study of CDX-622 in Participants With Mild to Moderate Asthma
Celldex Therapeutics
- Location
- Kansas City, KS + 3 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Endotronix, Inc.
- Location
- Kansas City, KS + 43 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
DalCor Pharmaceuticals
- Location
- Kansas City, KS + 112 other US sites
- Eligibility basics
- Ages 45+
- Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Abbott Medical Devices
- Location
- Kansas City, KS + 56 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
Rapamycin Holdings Inc.
- Location
- Kansas City, KS + 17 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Zucara Therapeutics Inc.
- Location
- Kansas City, KS + 36 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)
Cerus Endovascular, Inc.
- Location
- Kansas City, KS + 8 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
GC Biopharma Corp
- Location
- Kansas City, KS + 5 other US sites
- Eligibility basics
- Ages 18+